The FDA has granted Acuitive Technologies 510(k) marketing clearance for its Citrelock system, a device now cleared for attaching tissue during orthopedic surgeries.

The device is used in the fixation of ligaments or for tendon graft tissue repairs of the shoulder, elbow, wrist, hand, knee, ankle and foot.

The screw system uses Citregen, a synthetic biomaterial that includes a naturally occurring anti-microbial and anti-inflammatory molecule, citrate, to support tissue regeneration.